Method of gas and oil production from shale, oil sands and biomass using proppants and well safety options
    1.
    发明授权
    Method of gas and oil production from shale, oil sands and biomass using proppants and well safety options 有权
    使用支撑剂和井安全性选项从页岩,油砂和生物质生产天然气和石油的方法

    公开(公告)号:US08733439B1

    公开(公告)日:2014-05-27

    申请号:US13687378

    申请日:2012-11-28

    CPC classification number: E21B43/164 E21B43/2405 E21B43/267 Y02P90/70

    Abstract: Methods to recover over 95 percent of oil and gas from shale fracturing, oil sands, biomass, and hydrates and from deep water wells. Employing CO2, H2O2, some proprietary chemicals, metals and proppants, raising the temperature of the mixture and using the mixture in shale fracturing, oil sands, biomass and gas hydrates to dislodge the gas and oil. Additionally, safety devices capable of pressure reduction at the reservoir in the production well bore upstream of a BOP are included. No water is used and no waste water is produced.

    Abstract translation: 从页岩压裂,油砂,生物质和水合物以及深水井中回收95%以上油气的方法。 使用二氧化碳,二氧化二铪,一些专有化学品,金属和支撑剂,提高混合物的温度,并使用页岩压裂,油砂,生物质和天然气水合物中的混合物来驱除气体和油。 此外,还包括能够在BOP上游的生产井孔中的储层处减压的安全装置。 不使用水,不产生废水。

    Oral drug delivery system
    2.
    发明授权
    Oral drug delivery system 有权
    口服药物输送系统

    公开(公告)号:US08470367B2

    公开(公告)日:2013-06-25

    申请号:US11946575

    申请日:2007-11-28

    CPC classification number: A61K9/2072

    Abstract: An oral drug delivery system comprising a coated tablet having one or more surfaces. The coated tablet further comprises a core and a coating surrounding the core. The core comprises an active ingredient composition comprising at least one active ingredient and a pharmaceutically acceptable excipient and a composition selected from a swellable composition and a reactive composition located in an immediate vicinity of one or more preselected surfaces. The coating comprising water insoluble polymer(s) and leachable component(s) is operable to be reliably removed fully from the one or more of the preselected surfaces of the tablet upon contact with an aqueous environment, but not removed from at least one of the surfaces.

    Abstract translation: 一种口服药物递送系统,其包含具有一个或多个表面的包衣片剂。 涂布的片剂还包括芯和围绕芯的涂层。 核心包括活性成分组合物,其包含至少一种活性成分和药学上可接受的赋形剂,以及选自位于一个或多个预选表面附近的可溶胀组合物和反应性组合物的组合物。 包含水不溶性聚合物和可浸出组分的涂层可操作以在与水性环境接触时可靠地从片剂的一个或多个预选表面完全去除,但不从至少一个 表面。

    Large-scale targeted data distribution system
    4.
    发明授权
    Large-scale targeted data distribution system 有权
    大型目标数据分发系统

    公开(公告)号:US07765281B1

    公开(公告)日:2010-07-27

    申请号:US10715928

    申请日:2003-11-18

    CPC classification number: G06F9/44 G06F8/60 G06F15/16

    Abstract: A method, system, computer system and computer program product to distribute data to arbitrarily large subsets of a very large client base, with each client computer system running client software referred to as an agent. The data distribution system uses minimal server resources and a large-scale network such as the Internet. The data to be distributed may include, for example, agent software configuration data; agent software programs, plug-ins, and associated data; announcements; and other data that is centrally managed by an administrator. Using this invention, millions of client computer systems, such as computer systems for subscribers to a broadband service, can be configured and managed centrally, while allowing data to be distributed to all or a subset of subscribers efficiently and using minimal bandwidth. Agents assist in determining whether particular data are to be distributed to them, enabling much larger-scale applications to be supported with limited server-side resources.

    Abstract translation: 将数据分发到非常大的客户端的任意大的子集的方法,系统,计算机系统和计算机程序产品,每个客户端计算机系统运行被称为代理的客户端软件。 数据分发系统使用最少的服务器资源和诸如因特网之类的大规模网络。 要分发的数据可以包括例如代理软件配置数据; 代理软件程序,插件和相关数据; 公告 以及由管理员集中管理的其他数据。 使用本发明,可以集中地配置和管理数百万个客户端计算机系统,例如用于宽带服务的用户的计算机系统,同时允许数据被有效地分发给订户的全部或一部分,并且使用最小的带宽。 代理协助确定是否将特定数据分发给他们,从而能够通过有限的服务器端资源来支持更大规模的应用程序。

    Low cost selective octene process: RHT-octene
    5.
    发明授权
    Low cost selective octene process: RHT-octene 失效
    低成本选择性辛烯工艺:RHT-辛烯

    公开(公告)号:US07632976B2

    公开(公告)日:2009-12-15

    申请号:US11540179

    申请日:2006-09-29

    CPC classification number: C07C2/12 C07C2529/70 C07C11/02

    Abstract: This invention covers a process for making Octene from nix C4 Feed by a low cost highly selective multistage process. The multi staging of reactors essentially provides lower cost than conventional processes. Two options are provided in FIGS. 1 and 2 as regards to configuration based on the same catalyst but as can be seen that FIG. 1 configuration is low cost option with very high selectivity. The process provides conversion of butene to Octene >95% and product purity >96%. Product can be fractionated and can have a high purity Octene product by removing the trimers/polymers from the octene product. As mentioned due to the nature of the process configuration, one achieves high yield and selectivity with low cost.

    Abstract translation: 本发明涵盖了通过低成本高选择性多级方法从尼克斯C4进料制备辛烯的方法。 反应堆的多阶段基本上提供比常规方法更低的成本。 在图1和图2中提供了两个选项。 关于基于相同催化剂的构造的图1和图2,但是可以看出, 1配置是低成本选项,具有非常高的选择性。 该方法提供丁烯转化为蒎烯> 95%,产物纯度> 96%。 通过从辛烯产物中除去三聚体/聚合物,产物可以分馏并且可以具有高纯度的辛烯产物。 如上所述,由于工艺配置的性质,可以以低成本实现高产率和选择性。

    TRANSMUCOSAL COMPOSITION
    6.
    发明申请
    TRANSMUCOSAL COMPOSITION 审中-公开
    转运组合物

    公开(公告)号:US20090110717A1

    公开(公告)日:2009-04-30

    申请号:US12297486

    申请日:2007-04-25

    CPC classification number: A61K9/0056 A61K9/006 A61K9/2072 A61K9/2086

    Abstract: The invention provides a composition for delivering active agents through transmucosal administration, more particularly through the buccal mucosa. The composition is a unique transmucosal disk (10) which has two compartments (14) and (18); the compartments consist of at least one active agent and at least one mucoadhesive agent and both the compartments are adapted to be in contact with the mucosal membrane. The invention also provides for transmucosal administration of an active agent and method of treatment of diseases in a subject in need of such treatment.

    Abstract translation: 本发明提供了一种用于通过经粘膜给药递送活性剂的组合物,更具体地通过颊粘膜递送。 该组合物是独特的经粘膜盘(10),其具有两个隔间(14)和(18); 隔室由至少一种活性剂和至少一种粘膜粘附剂组成,并且两个隔室都适于与粘膜接触。 本发明还提供活性剂的经粘膜给药和治疗需要这种治疗的受试者的疾病的方法。

    COMBINED USE OF ULTRASOUND AND GROWTH FACTORS TO STIMULATE BONE FORMATION
    7.
    发明申请
    COMBINED USE OF ULTRASOUND AND GROWTH FACTORS TO STIMULATE BONE FORMATION 审中-公开
    联合使用超声波和生长因子刺激骨形成

    公开(公告)号:US20080255049A1

    公开(公告)日:2008-10-16

    申请号:US12101031

    申请日:2008-04-10

    CPC classification number: A61N7/00

    Abstract: The combination of low intensity pulsed ultrasound with administration of an osteogenic protein or proteins or their genes enhances bone repair in mammals. This combination avoids thermal activation of tissue repair mechanisms and allows the osteogenic protein or proteins or their genes to act at the site of bone fracture or lowered bone density to enhance or accelerate bone formation, thereby improving the prognosis of a patient. The combination may be used to treat fractures, to prevent or treat osteoporosis, to improve outcomes for bone replacement and to prevent or treat bone loss due to other physiologic disorders.

    Abstract translation: 低强度脉冲超声与施用成骨蛋白或蛋白质或其基因的组合增强了哺乳动物的骨修复。 这种组合避免了组织修复机制的热激活,并允许成骨蛋白质或蛋白质或其基因在骨折部位起作用或降低骨密度以增强或加速骨形成,从而改善患者的预后。 该组合可用于治疗骨折,预防或治疗骨质疏松症,改善骨替代的结果,并预防或治疗由于其他生理障碍引起的骨丢失。

    Optical encoder
    8.
    发明授权
    Optical encoder 有权
    光学编码器

    公开(公告)号:US07244928B2

    公开(公告)日:2007-07-17

    申请号:US11031280

    申请日:2005-01-07

    CPC classification number: G01D5/34746 G01D5/347 G01D5/34707

    Abstract: An optical encoder includes a code strip having a first side, a second side, a first track comprising indicia thereon, and a second track comprising indicia thereon. The code strip is moveable along a displacement path with respect to the optical encoder. A light source positioned on the first side of the code strip directs light toward the code strip. A first detector element is positioned on the second side of the code strip and is generally aligned with the first track of the code strip. A second detector element is positioned on the second side of the code strip and is generally aligned with the second track of the code strip. The second detector element is also positioned so that the second detector element is located a spaced distance along the displacement path from the first detector element.

    Abstract translation: 光学编码器包括具有第一侧,第二侧,其上包括标记的第一轨道和其上包括标记的第二轨道的码带。 编码条可以沿相对于光学编码器的位移路径移动。 位于代码带的第一侧上的光源将光朝着码条引导。 第一检测器元件位于代码条的第二侧上,并且通常与代码条的第一轨迹对齐。 第二检测器元件位于代码条的第二侧上,并且通常与代码条的第二轨迹对齐。 第二检测器元件也被定位成使得第二检测器元件沿着与第一检测器元件的位移路径间隔开距离。

    Pharmaceutical composition comprising cyclosporin
    9.
    发明授权
    Pharmaceutical composition comprising cyclosporin 失效
    包含环孢菌素的药物组合物

    公开(公告)号:US06346511B1

    公开(公告)日:2002-02-12

    申请号:US09568007

    申请日:2000-05-10

    CPC classification number: A61K9/4858 A61K47/10 A61K47/14 A61K47/44

    Abstract: A homogenous substantially alcohol free composition of Cyclosporin which comprises a cyclosporin in a hydrophilic carrier medium comprising propylene glycol, esters of propylene glycol with C4 to C12 fatty acids and polyoxyethylene hydrogenated castor oils wherein the ingredients are present in the following range, Cyclosporin 1-25% w/w, Propylene Glycol 2.5-70% w/w, Esters of propylene glycol with C4 to C12 fatty acids 2.5-70% w/w and Polyoxyethylene hydrogenated Castor oils 2.5-70% w/w.

    Abstract translation: 一种均匀的基本上无醇的环孢菌素组合物,其在包含丙二醇的亲水载体介质中包含环孢菌素,丙二醇与C 4 -C 12脂肪酸的酯和聚氧乙烯氢化蓖麻油,其中所述成分以下列范围存在:环孢菌素1-25 %w / w,丙二醇2.5-70%w / w,丙二醇酯,C4-C12脂肪酸酯,2.5-70%w / w,聚氧乙烯氢化蓖麻油为2.5-70%w / w。

Patent Agency Ranking